Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares
-
Brødrene A & O Johansen A/S acquires leading e-commerce domain "VVS-eksperten.dk" with effect from 1 Januar 2026
-
Invesco Ltd: Form 8.3 - Qualcomm Incorporated; Public dealing disclosure
-
Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
FTI Consulting Enhances Private Equity Expertise with Addition of Strategy and Transformation Expert Josh Harris
-
Guardforce AI Reports Full-Year 2024 Financial Results and Provides Business Update
-
Veri Medtech (VRHI) Retains PCAOB Auditor
-
Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST
-
Embecta to host Analyst and Investor Day on May 22, 2025
-
Montage Gold Announces Graduation to the Toronto Stock Exchange
-
BitMart Shines at TOKEN2049 Dubai: A Pinnacle Moment of Innovation and Global Impact
-
BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development
-
Exodus Movement, Inc. to Announce First Quarter 2025 Results on May 12, 2025
-
Crescent Biopharma Appoints David Lubner to Board of Directors
-
Nano Dimension to Host 2024 Financial Results and 2025 Outlook Conference Call
-
FitLife Brands Announces Board Transition
-
Tornado Infrastructure Equipment Reports Record 2024 Results
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
TikTok’s Favorite Foodie Kate Norkeliunas Teams Up with MGA’s Miniverse™ to Launch Make It Mini From Scratch™, The Collectible You Make Yourself
-
ElevateBio Announces Transition of David Hallal to Executive Chairman of the Board of Directors
-
NANO Nuclear Announces Full Dismissal of Nevada Lawsuit
-
Share buy-back program
-
Chengdu Will Mark 100-day Countdown to TWG 2025 Chengdu
-
EBC Financial Group Deepens Commitment to United to Beat Malaria with Renewed Global Partnership and First-Ever 5K Run Sponsorship
-
Microchip Expands Connectivity, Storage and Compute Portfolios to Meet the Growing Demands of AI Data Center Applications
-
Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025
-
Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025
-
Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma
-
Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting
-
BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025
-
Biomed Valley Discoveries Announces First Patient Dosed in Phase 1/2 Combination Study of Ulixertinib with Ruxolitinib (Jakafi®) in Patients with Myelofibrosis
-
Hudbay’s Eugene Lei wins Globe and Mail’s Report on Business 2025 Best Executive Award
-
EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease
-
Kandi Technologies Reports 2024 Financial Results
-
Nayax to Showcase End-to-End Payment Ecosystem at The NAMA Show, May 7-9 in Las Vegas
-
Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
-
Matador Technologies Inc. Announces Symbol Change and DTC Eligibility of its Common Shares
-
Atana Expands Sales Team, Welcomes New Leaders to Drive Continued Growth
-
Clear Blue Technologies International to provide Corporate Update and Report Fiscal 2024 Financial Results and Host Conference Call on Thursday, May 1st, 2025
-
Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-posit
-
Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
-
Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at 2025 AACR Annual Meeting
-
G2 Continues to Expand New Surface Gold Discovery and Provides Exploration Update
-
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
-
XORTX Announces Grant of European Patent
-
Barrick Gold Corporation Plans to Change Name to BARRICK MINING CORPORATION
-
Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
-
Beamr to Participate in Upcoming Investor Conferences in May 2025
-
ScottsMiracle-Gro CEO Reports Strong POS Unit Gains During CNBC Mad Money Appearance

